Respiratory - Breathlessness: Restrictive Lung Disease Flashcards
Primary restrictive lung disease
Disease of lung parenchyma
Secondary restrictive lung disease
Chest wall and pleural disease
What does restrictive lung disease cause difficulty in
Inhaling
Reduced elasticity resulting in poor lung expansion
What are some mediators of infl
Leukocytes
Cytokine
Complement pathway proteins
The 5 R’s of infl & repair
Recognition of the injurious agent Recruitment of the leukocytes Removal of the agents Regulation of the response Resolution/ repair
Why does lung fibrosis result in SOB
Pts will have dyspnoea, tachypnoea, fine end inspiratory crackles
A/c lung injuries
ARDS
Pneumonia
Mortality of ARDS
50%
ARDS
A/c Resp Distress Syndrome
What is ARDS
Primary resp failure characterised by refractory hypoxaemia and bilateral radiological evidence of alveolar collapse
No other attributable cause
What does ARDS end in
Vascular non-responsiveness
Leading to multiorgan failure due ton c/c hypoxia and effects of infl mediators
How can causes of ARDS be classified
Direct/ indirect lung injury
Common and uncommon
Common causes of ARDS - direct lung injury
Pneumonia
Aspiration of gastric contents
Uncommon causes of ARDS - direct lung injury
Pulmonary contusion
Inhalation injury
Fat emboli
Reperfusion injury
Common causes of ARDS - indirect lung injury
Sepsis
Severe trauma and shock
Uncommon causes of ARDS - indirect lung injury
Post-cardiac surgery
Pancreatitis
Drug overdose
Phases of ARDS
Exudative
Regernative
Repair
Exudative phase of ARDS
Necrosis of Type 1 pneumocytes then exposure and subsequent loss of the underlying basement membrane, fibrin release +/- haemorrhage, pulmonary collapse
How long does the exudative phase of ARDS last
~7/7
Regenerative phase of ARDS
Proliferation of pneumocytes and connective tissue
Infl
How long does the regenerative phase of ARDS last
1-2 weeks post injury
Repair stage of of ARDS
Infl, proliferating fibroblasts in the connective tissue produce granulation tissue (organising pneumonia) and/ or fibrous scar tissue
How long does the repair stage of ARDS last
2 weeks plus
Why is long intensive care required in ARDS
Pt have v high mortality weeks after initial event
Stages of pneumonia
A/c
Early resolving
Organising
From here there’ll either be complete resolution to normal or may go onto develop interstitial fibrosis
A/c stage of pneumonia
Neutrophil infiltrates into bronchi and alveoli
Early resolving stage of pneumonia
Fibrin, some neutrophils also macrophages, lymphocytes in air spaces
What can granulomatous responses in the lungs be caused by
Foreign bodies: inhaled exogenous substances e.g. beryllium
Infections: TB, fungi
Immune: hypersensitivity pneumonitis
unknown sarcoidosis
What is hypersensitivity pneumonitis
A c/c disease of the lungs resulting from inhalation of foreign substances showing both granulomatous and hypersensitivity reactions
Pathogen acts as a foreign antigen and triggers a local hypersensitivity reactions
What is hypersensitivity pneumonitis also known as
Extrinsic allergic alveolitis
Sources of exposure leading to hypersensitivity pneumonitis
Mouldy hay - Farmer's lung Mouldy grain - Grain handler's lung Pigeons, parakeets, fowl - Bird breeder's lungs Cheese mould - cheese worker's lung Paprika dust - Paprika splitter's lung Infested wheat - wheat weevil
C/c fibrosis ILD
Pnuemoconiosis Idiopathic pulmonary fibrosis/ UIP CTD Radiation Drugs
COP
NSIP
COP
Cryptogenic organising pneumonia
NSIP
Non-spp interstitial pneumonia
Pneumoconiosis
‘Dusty lung disease’
Permanent alteration of lung structures due to the inhalation of mineral dust and the tissue recitations of the lung to its presence
Commonest pneumoconiosis
Silicosis
Where does pneumoconiosis tend to be worse
In the upper lobes
This is due to more aeration of the lower lobes and better removal of particulate material
Pulmonary reactions seen in pneumoconiosis
Macrophage accumulation w/ a little reticulin deposition Nodular or massive fibrosis Diffuse fibrosis Epitheliod and giant cell granulomas Alveolar lipoproteinosis Small-airway disease
Dust identification - pneumoconiosis
Clinical hx
Radiology - distribution of lung changes, upper, lower zones, nodule and fibrosis
Colour of the dust particles
Histology - refractory particles, crystal shape
What are asbestos related diseases
A family of pro-infl crystalline hydrated silicates
Crystals once phagocytosed activate an infl response which stimulates the release of proinfl factors and fibrogenic mediators
Macrophages attempt to phagocytose and digest fibres
What are asbestos related diseases associated with
Number of pulmonary and extra pulmonary diseases
Sequela of asbestos related diseases
Pleural plaques
Pleural effusions
Pulmonary fibrosis (asbestosis)
Malignancy - lung carcinoma, mesothelioma, extra pulmonary
Clinical findings of asbestosis
SOB
Dry cough
Finger clubbing
Macroscopic findings of asbestosis
Subpleural fibrosis particularly lower lobes
Microscopic findings of asbestosis
Intersititial fibrosis: peri bronchial and sub pleural ad the presence of ferruginous bodies
Resolution of asbestosis
The persistent c/c infl nature o d the disease is such that there is no disease resolution
What is idiopathic pulmonary fibrosis also known by
Its histological pattern: UIP
What is idiopathic pulmonary fibrosis
Progressive interstitial pulmonary fibrosis and reps failure caused by persistent epithelial injury and abnormal immune reaction
Cause of idiopathic pulmonary fibrosis
No known cause
Who do we see idiopathic pulmonary fibrosis in
Arises in genetically predisposed individuals who are prone to aberrant repair of recurrent alveolar injury
Secondary causes of lung fibrosis - Reactions to treatment
Drugs - various meds may cause a/c/ and c/c alteration in lung structure
Radiation pneumonitis
Types of radiation pneumonitis
A/c
C/c
A/c radiation pneumonitis
1/12 - 6/12 after treatment
May resolve completely w/ steroids or go on to a hypersensitivity pnuemoniti pattern
C/c radiation pneumonitis
Results in pulmonary fibrosis
Can also occur without a/c phase
Secondary causes of lung fibrosis - lung in systemic disease
Pulmonary - CTD
Extra-pulmonary - condns that limit MSK system or pleura e.g. scoliosis, and soon, neurodegenerative disease
Residual and functional volumes in obstructive disease
Increased
Inspiratory residual volume and inspiratory capacity in restrictive disease
Decreases
Examples of restrictive lung diseases
Fibrotic changes
Scoliosis
Muscular dystrophy
Ank spon
Atelectasis
Imperfect expansion off lungs
Specifically of failure of lungs to expand fully at birth
Congenital airway obstruction due to lack of surfactant in prematurity
Secondary atelectasis
Pulmonary collapse
Pressure changes and alveolar gas not replenished (absorption collapse) - obstruction prevents free entry of air into lungs
Epidemiology of sarcoidosis
2nd most common c/c reps disease in <40s
Bimodal distribution - 25-40 and 65+
Aetiology of sarcoidosis
Poorly understood - related to genetic predisposition plus exposure to antigen
Non-caeseating granulomas lead to organ damage and dysfunction
Which type of sarcoidosis manifestation has a better prognosis
A/c
What % of sarcoidosis develop c/c symptoms
1/3
Usually have non-spp, systemic symptoms
Pathophysiology of sarcoidosis
Antigen and host protein form a poorly soluble compound –. APCs activate macrophages & dendritic cells, producing cytokines –> Th1 help form epithelium granulomas
What does sarcoidosis chronicity depend on
Ability to clear antigen
Genetic causes of sarcoidosis
Multiple area of the HLA region BTNL2
ANXA11
Causes of sarcoidosis - exposures
Beryllium, silic, other dust
Mycobacterium tuberculosis and Propionibactera catalases
Moulds
How is sarcoidosis usually discovered
Incidental finding - no symptoms suggestive of sarcoidosis
Good prognosis
A/c presentation of sarcoidosis
Flu-like illnesses
Lofgren’s syndrome
Good prognosis - >605 in 2 yrs
Lofgren’s syndrome
Bilateral hilar lymphadenopathy
Erythema nodusum
Arthralgia
Who do we typically see Lofgren;s syndrome in
Northern Europeans/ caucasians
C/c presentation of sarcoidosis
Progressive symptoms (e.g. dyspnoea, cough) Associated extra-pulmonary disease and organ dysfunction
Eye involvement in sarcoidosis
Uveitis Lacrimal gland involvement Optic nerve involvement Glaucoma Granulomatous tissue within orbit
Neurological involvement in sarcoidosis
Neuropathy
Meningitis
Raised ICP
Psychiatric problems
Resp tract involvement in sarcoidosis
Lymphadenopathy
ILD/ scarring
Airway obstruction and stenosis
Skin involvement in sarcoidosis
Erythema nodusum
S/c nodules
Lupus pernio
MSK involvement of sarcoidosis
Myositis
Arthralgia and arthritis
Entheistis
Cardiac involvement in sarcoidosis
Arrhythmia
Ventricular infiltration and failure
SCD
GI and GU involvement in sarcoidosis
Nephrocalcinosis
IBD mimic
Infertility
Obtruscive liver disease
What metabolic disturbance is seen in sarcoidosis
Hypercalcaemia
Eye symptoms in sarcoidosis
Eye pian
Visual disturbance
Vision loss
Resp symptoms seen in sarcoidosis
Breathlessness (exertional)
Cough
Wheeze
Neuro symtpoms seen in sarcoidosis
Seizures
Headaches
Cranial nerve palsies
GI and GU symptoms seen in sarcoidosis
Abdominal pain
Haematuria
Deranged LFTs
Change in bowel habits
Lymphadenopathy seen in pulmonary sarcoidosis
Mediastinal and hilar
bIlateral and symmetrical
Parenchymal disease seen in pulmonary sarcoidosis
Nodularity following bronchovacsular bindles and adjacent to tissues
Nodular disease (incl conglomerate masses)
Fibrosis
Airway disease in pulmonary sarcoidosis
Asthma-like symptoms/ bronchial hyper-reactivity (cough predominant)
Airway stenosis and occlusion
Which cardiac manifestations of sarcoidosis require mx
Dyspnoea Collapse CM SCD/ arrythmias Pulmonary HTN
Which neurological manifestations of sarcoidosis require mx
Seizures
Aseptic meningitis
Cranial nerve palsies
Which metabolic manifestations of sarcoidosis require mx
Hypercalcaemia
Hypercalciura/ renal calculi
Which opthalmic manifestations of sarcoidosis require mx
Uveitis
Visual loss
Sarcoidosis mimics
C/c berylliosis - clinically identical but w/ clear exposure to beryllium
Granulomatous reactions to malignancy - context of known malignancy
Granulomatous - lymphocytic ILD (occurs in immune deficiency)
Drug reactions - anti-TNF monoclonal antibodies
Ix for sarcoidosis
Bloods
PFTs
CXR preceding tio CT chest
ECG (look for heart block)
Bloods for sarcoidosis
FBC - lymphopenia, anaemia
U&Es - renal dysfunction
LFTs - derangement (obstructive or hepatotoxic)
Serum ACE - elevated commonly but NOT spp
Ig - association w/ Ig defences esp IgA
Pulmonary function tests in sarcoidosis
Any pattern can occur (obstructive most common)
Radiology for sarcoidosis
Looking for subtle parenchymal changes in lungs or any asymmetry to suggest alternative pathologies
CXR staging for sarcoidosis
Stage I to IV
Stage I sarcoidosis - radiological
Bilateral hilar lymphadenopathy
Stage I sarcoidosis - radiological
Bilateral hilar lymphadenopathy
Increased paratracheal stripe
Stage II sarcoidosis - radiological
BHL and pulmonary infiltrates
Stage III sarcoidosis - radiological
Pulmonary infiltrates without BHL
Stage IV sarcoidosis - radiological
Advanced pulmonary fibrosis
Loss of lung volume
Apical fibrotic change
Which stage of sarcoidosis is most pts in
Stage I
Reolustion of 60-90%
Which stage of sarcoidosis is most pts in
Stage I
Reolustion of 60-90%
Which stage of sarcoidosis is most pts in
Stage I
Resolution of 60-90%
CT findings for sarcoidosis
Hilar and mediastinal nodes - symmetrical, bilayer enlargement
Nodules
Fibrotic changes
Bronchoscopy for pulmonary sarcoidosis
Pts are likely to require biopsy from lungs
Done at same time
Possible targets for lung biopsies - pulmonary sarcoidosis
Endobronchial lesions – cobble stoning
Transbronchial biopsies – more risky
EBUS-TBNA – biopsy of lymph nodes, helps rule out metastaic malignancy
Treatment for pulmonary sarcoidosis
Majority of pts will not require immediate treatment; raise w/ more severe disease require early mx
Reasons to initiate treatment in sarcoidosis
Wells Law
Danger of damage of organs (incl preventing mortality)
Improve QoL
Reasons to initiate treatment in sarcoidosis
Wells Law
Danger of damage of organs (incl preventing mortality)
Improve QoL
1st line drug of sarcoidosis
40-60mg Prednisolone - weaned over 6-18 months
1st line drug of sarcoidosis
40-60mg Prednisolone - weaned over 6-18 months
2nd line drugs for sarcoidosis
MTX - 10-15mg once weekly
Azathioprine - 1-3mg/kg - good for neuro-sarcoid
SE of MTX
Cytopenias
GI side-effects
Pneumonitis
SE of azathioprine
Cytopenias
GI side effects
LFT derangement
3rd line drugs for sarcoidosis
Mycophenolate Mofetil
Hydroxychloroquine
Anti-TNF
Mycophenolate
Cytopenias
GI side effects
LFTs derangement
SE of hydroxychloroquine
Optic neuritis
Follow up for Lofgren’s syndrome (Stage I CXR)
6 monthly for 2 yrs
Follow up for Stage II - IV sarcoidosis CXR
3-6 monthly or annually
Depending on clinical suspicion of a change in disease behaviour
No discharge
Follow up of pulmonary sarcoidosis pts who’ve been withdrawed from steroid therapy
2-3 monthly or 3-6 monthly
Minimum 3 years after cessation
No discharge
Mortality and sarcoidosis
Mortality attributable to sarcoidosis in pts w/ significant disease manifestations are more like 25%
Diffuse Parenchymal Lung diseases (DPLD)
Vast majority cause restrictive PFTs
Gradual onset breathlessness
Frequently cause cough
Will hear inspiratory carpitations
Causes of DPLD
Idiopathic interstitial pneumonia
Spp cause - drugs, hypersensitivity pneumonitis, CTD
Granulomatous - sarcoidosis
What is seen in the interstitium
ECM
Fibroblasts
Aetiology of DPLD
Drugs, therapies, iatrogenic - bleomycin, amiodarone
Inhalation of dusts (occupation, environment)
CTD (collagen diseases)
Unknown (idiopathic)
Idiopathic Interstitial Pneumonia
IDO NSIP COP Resp bronchiolitis ILD (R-BILD) Desquamative Interstitial Pneumonia (DIP) A/c interstitial pneumonia
CT of UIP
Honeycombing +/- traction bronchiectasis
Epidemiology of NSIP
40-50yrs
M>F
Better prognosis than IPF
May be associated w/ CTD
CT of NSIP
Ground glass
Reticular shadowing
CT of COP
Consolidation or nodules
R BILD
Exaggerated bronchiolitis response to smoking
CT of R BILD
Patchy ground glass
Centrilolobular micro nodules
Regional attenuation
Who do we see DIP in
Heavy smokers
CT of DIP
Ground glass opacities
Bronchial thickening
CT of a/c interstitial pneumonia
Consolidation
Ground glass
What type of hypersensitivity reaction causes hypersensitivity pneumonitis
Type III or Type IV
Mx of hypersensitivity pneumonitis
Removal from antigen
Steroids
Examination finding in pts w/ restrictive lung disease
Fibrosis - fine end inspiratory crackles/ crepitation
Sarcoidosis - normal
Hypersensitivity pneumonitis - crackles, wheeze, squeaks
Main ix for restrictive lung disease
Pulmonary function tests
Bloods
Radiology
Blood for restrictive lung disease
FBC (eos)
U&ES
LFT
Serological - ANA,, RhF, anti-CCP, spp IgG’s
Other tests for restrictive lung disease
ECG
Echo
Radiology - CXR
HRCT of chest in restrictive lung disease
Ground glass - non spp Consolidation Reticular shadowing* Traction bronchiectasis* Honeycombing*
- signs of fibrosis
Ground glass appearance on HRCT
Hazy Opoacity that doesn’t obscure the associated pulmonary vessels
What causes a ground glass appearance
Parenchymal abnormalities - infl or fibrosis
MDT for restrictive lung disease
Physician
Radiologist
Pathologist
Treating fibrosis in restrictive lung disease
Anti-fibrosis
Only for IPF (progressive fibrosis on named pt basis)